Inactive Instrument

News Actelion

Equities

ATLN

CH0010532478

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Actelion : Pharmaceuticals US, Inc, - Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents	20-04-06	AQ
Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017	17-10-31	GL
Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake	17-07-31	RE
Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	17-07-18	RE
Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	17-07-18	RE
Actelion : Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung	17-06-30	GL
Actelion : Johnson & Johnson Completes Acquisition of Actelion	17-06-16	GL
Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange	17-06-15	PU
Actelion : announces changes to its executive team upon completion of the transaction with Johnson & Johnson	17-06-14	GL
Spin off	17-06-13	FA
Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	17-06-09	RE
Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	17-06-09	RE
Actelion : Johnson & Johnson expects to complete of Actelion offer on June 16	17-06-09	RE
Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange	17-06-09	GL
Actelion : Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017	17-06-09	GL
Actelion : provides an update on the Phase III IMPACT program with cadazolid in CDAD	17-06-08	GL
Akzo Nobel : Cross-border M&A between U.S. and European firms at 10 year high	17-05-22	RE
Actelion : provides an update on the progress towards launching Idorsia - Key results for pipeline assets to be developed by Idorsia	17-05-22	GL
Actelion : Johnson & Johnson offers EU concessions over Actelion deal	17-05-18	RE
Actelion : announces changes to its executive team upon completion of the transaction with Johnson & Johnson	17-05-15	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Actelion

Equities

ATLN

CH0010532478

Summary

Filters